BOSTON SCIENTIFIC CORP — Director's Dealing 2019

Apr 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-04-15

Reporting Person: Nanavaty Maulik (SVP & Pres, Neuromodulation)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-15	Common Stock	M	3039.0000	$7.4100	Acquired	257508.0000	Direct
2019-04-15	Common Stock	S	3039.0000	$37.8100	Disposed	254469.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-15	Stock Option (Right to Buy)	$7.4100	M	3039.0000	Disposed	2020-02-16	Common Stock (3039.0000)	Direct

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual increments beginning on February 16, 2011, the first anniversary of the date of grant.